A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

11.1K views

⸱

DOI:

10.3791/51522

⸱

May 15th, 2014

In This Article

Summary

We describe the usage of a fluorescent reporter vaccinia virus that enables real-time measurement of viral infectivity and gene expression through the stage-specific expression of spectrally distinct reporter fluorophores. We detail a plate-based method for accurately identifying the stage at which virus replication is affected in response to small molecule inhibition.

Abstract

Poxviruses are a family of double stranded DNA viruses that include active human pathogens such as monkeypox, molluscum contagiousum, and Contagalo virus. The family also includes the smallpox virus, Variola. Due to the complexity of poxvirus replication, many questions still remain regarding their gene expression strategy. In this article we describe the conceptualization and usage of recombinant vaccinia viruses that enable real-time measurement of single and multiple stages of viral gene expression in a high-throughput format. This is enabled through the use of spectrally distinct fluorescent proteins as reporters for each of three stages of viral replication. These viruses provide a high signal-to-noise ratio while retaining stage specific expression patterns, enabling plate-based assays and microscopic observations of virus propagation and replication. These tools have uses for antiviral discovery, studies of the virus-host interaction, and evolutionary biology.

Introduction

Traditionally, virus expression is studied using molecular biology techniques (e.g. northern blotting, western blotting, microarray hybridization, etc.) 1. While these methods are capable of providing detailed information with respect to categorizing expression changes of individual mRNAs or proteins, they are typically not amenable to real-time and high-throughput processes. Alternative approaches using fluorescence-based reporters have been applied previously when working with poxviruses; however, their development and usage has been motivated by varied aims. Several such methods were designed for selection of recombinant viruses 2,....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Plate Cells

  1. Dissociate HeLa cells from plate and dilute in growth media (DMEM, 2 mM L-glut, 10% FBS) to approximately 2.0 x 105 cells/ml. Dispense 100 μl/well in a black-walled, clear flat-bottom 96-well plate (20,000 cells/well).
  2. Incubate cells for 24 hr until confluent in a 37 °C incubator + 5% CO2.

2. Infect Cells

  1. Dilute virus and infect cells.
    1. Thaw TrpV (Triple virus; Early Venus, Intermediate mCherry, Late TagBFP) and PLV (Promoter-less Venus) fluorescent virus and disaggregate using sonication for 5 minutes. Alternatively, crude virus stocks can be....

Access restricted. Please log in or start a trial to view this content.

Results

As an example of the typical usage of these viruses, the triple fluorescence-reporter virus was used to compare the point of inhibition of several well-defined poxvirus inhibitors.

HeLa cells were plated in tissue culture treated black-walled clear flat-bottom 96-well plates and incubated overnight. Confluent monolayers were infected at a multiplicity of infection (MOI) of 10 using either triple reporter virus (TrpV; Table 1) or promoter-less Venus (PLV) as detailed on the pla.......

Access restricted. Please log in or start a trial to view this content.

Discussion

 Here, we have described the practical usage of a multi-stage vaccinia reporter virus (TrpV), which provides reproducible, real-time feedback measures of virus replication. By using well-defined poxvirus inhibitors, we were able to show that TrpV responds in a manner consistent with the understood mechanism of action for each inhibitor. While the TrpV virus provides the most comprehensive information about virus stage progression, two-stage (IREV, LREV) and single-stage (EV, IV, LV) viruses can also be used similarl.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose and no patents are pending for viruses or screening methods.

Acknowledgements

We thank SIGA Technologies (Corvallis, OR) for providing ST-246. D.K.R. was supported by an NIH training grant in immunology to Boston University (5T32AI 7309). This work was supported in part by P41 086180, NIH RO1AI1096159-01, and RO3  (to J.H.C.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Dulbecco's Modified Eagle Medium (DMEM)Gibco11995-065
Fetal Bovine Serum - Optima, Heat Inactivated (FBS)Atlanta BiologicalsS12450H
200 mM L-Glutamine, (L-glut)Gibco25030-081
96 Well Flat Clear Bottom Black Polystyrene TC-Treated MicroplatesCorning3603
384 Well Flat Clear Bottom Black Polystyrene TC-Treated MicroplatesCorning3712
Trypsin, 2X, Sterile, IrradiatedWorthington Biochemical Corp.TRLVMF
Phosphate-Buffered Saline (PBS)Gibco10010-023
Dimethyl Sulfoxide, Cell Culture (DMSO)American BioanalyticalAB03091
1-β-D-Arabinofuranosylcytosine  (AraC), MW= 280 g/molSigmaAldrich CoC6645
isatin β -thiosemicarbazone (IBT), MW= 234 g/molFisher ScientificNC9075202
Rifampicin, MW= 823 g/molSigmaAldrich CoR3501
ST-246, MW= 376 g/molSIGA Labs, Corvallis, OR
8% Paraformaldehyde (formaldehyde) aqueous solutionElectron Microscopy Sciences157-8
TempPlate RT optically clear filmUSA Scientific2978-2700
Opti-MEM Reduced Serum MediumGibco31985-070

References

  1. Yen, J., Golan, R., Rubins, K. Vaccinia virus infection & temporal analysis of virus gene expression: part 1. J Vis Exp. 26 (26), (2009).
  2. Hansen, S. G., Cope, T. A., Hruby, D. E. BiZyme: a novel fusion protein-med....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Vaccinia VirusViral Gene ExpressionTriple Reporter VirusFluorescent Protein ReportersPlate Reader AssayFluorescence QuantificationAntiviral DiscoveryVirus-Host InteractionRNAi ScreensSpectrally Distinct Fluorescence